These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

743 related items for PubMed ID: 21778221

  • 1. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.
    Nannipieri M, Mari A, Anselmino M, Baldi S, Barsotti E, Guarino D, Camastra S, Bellini R, Berta RD, Ferrannini E.
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1372-9. PubMed ID: 21778221
    [Abstract] [Full Text] [Related]

  • 2. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M, Baldi S, Mari A, Colligiani D, Guarino D, Camastra S, Barsotti E, Berta R, Moriconi D, Bellini R, Anselmino M, Ferrannini E.
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB, Jacobsen SH, Dirksen C, Bojsen-Møller KN, Naver L, Hvolris L, Clausen TR, Wulff BS, Worm D, Lindqvist Hansen D, Madsbad S, Holst JJ.
    Am J Physiol Endocrinol Metab; 2012 Jul 01; 303(1):E122-31. PubMed ID: 22535748
    [Abstract] [Full Text] [Related]

  • 5. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
    Jiménez A, Casamitjana R, Flores L, Delgado S, Lacy A, Vidal J.
    Ann Surg; 2013 May 01; 257(5):894-9. PubMed ID: 23579541
    [Abstract] [Full Text] [Related]

  • 6. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
    Kadera BE, Lum K, Grant J, Pryor AD, Portenier DD, DeMaria EJ.
    Surg Obes Relat Dis; 2009 May 01; 5(3):305-9. PubMed ID: 19460674
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
    Kashyap SR, Daud S, Kelly KR, Gastaldelli A, Win H, Brethauer S, Kirwan JP, Schauer PR.
    Int J Obes (Lond); 2010 Mar 01; 34(3):462-71. PubMed ID: 20029383
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study.
    Pontiroli AE, Pizzocri P, Librenti MC, Vedani P, Marchi M, Cucchi E, Orena C, Paganelli M, Giacomelli M, Ferla G, Folli F.
    J Clin Endocrinol Metab; 2002 Aug 01; 87(8):3555-61. PubMed ID: 12161474
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp.
    Lima MM, Pareja JC, Alegre SM, Geloneze SR, Kahn SE, Astiarraga BD, Chaim EA, Geloneze B.
    J Clin Endocrinol Metab; 2010 Aug 01; 95(8):3871-5. PubMed ID: 20484482
    [Abstract] [Full Text] [Related]

  • 14. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes.
    Geloneze B, Tambascia MA, Pareja JC, Repetto EM, Magna LA, Pereira SG.
    Obes Surg; 2001 Dec 01; 11(6):693-8. PubMed ID: 11775566
    [Abstract] [Full Text] [Related]

  • 15. Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.
    Pereira JA, Lazarin MA, Pareja JC, de Souza A, Muscelli E.
    Obes Res; 2003 Dec 01; 11(12):1495-501. PubMed ID: 14694214
    [Abstract] [Full Text] [Related]

  • 16. Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation.
    Burstein R, Epstein Y, Charuzi I, Suessholz A, Karnieli E, Shapiro Y.
    Int J Obes Relat Metab Disord; 1995 Aug 01; 19(8):558-61. PubMed ID: 7489026
    [Abstract] [Full Text] [Related]

  • 17. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function.
    Mari A, Manco M, Guidone C, Nanni G, Castagneto M, Mingrone G, Ferrannini E.
    Diabetologia; 2006 Sep 01; 49(9):2136-43. PubMed ID: 16819611
    [Abstract] [Full Text] [Related]

  • 18. Differential effect of weight loss on insulin resistance in surgically treated obese patients.
    Muscelli E, Mingrone G, Camastra S, Manco M, Pereira JA, Pareja JC, Ferrannini E.
    Am J Med; 2005 Jan 01; 118(1):51-7. PubMed ID: 15639210
    [Abstract] [Full Text] [Related]

  • 19. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass.
    Hamza N, Abbas MH, Darwish A, Shafeek Z, New J, Ammori BJ.
    Surg Obes Relat Dis; 2011 Jan 01; 7(6):691-6. PubMed ID: 20688578
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.